ArticleCureus2025
Managing Laryngeal Carcinoma in the United Arab Emirates: An Experience From the Tertiary Care Center.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Laryngeal cancer is a common head and neck malignancy. The treatment modalities differ depending on the clinical staging and location of the tumor, hence affecting the survival outcomes. Objective This study aims to provide demographic information and survival outcomes in laryngeal cancer patients in the UAE, considering the clinical staging and treatment received. Methods A retrospective cohort study in laryngeal cancer patients at Tawam Hospital from 2016 to 2020. Descriptive analysis summarized the demographics and survival analysis using Kaplan-Meier curves, comparing outcomes between early and advanced stages, as well as treatment modality (surgical vs non-surgical). We also used the log-rank test to assess statistical significance. Results A total of 63 patients were included in the study. Patients with early-stage disease showed better survival in the surgical compared to the non-surgical primary treatment. On the contrary, patients with advanced-stage disease had better survival outcomes in the non-surgical treatment group than in the surgical group. Conclusion Compared to early-stage disease, the treatment modality does affect the survival outcomes in advanced stages. These results suggest a potential benefit favoring the non-surgical treatment modality, but further prospective studies with larger sample sizes are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.